Susan Anton
Icon has expanded its risk management as well as its early phase development leadership teams.
Susan Anton has become the director of epidemiology and risk management for the Irish CRO’s (contract research organisation) late phase and outcomes sector.
She joins the firm from Boehringer Ingelheim, where she was director of US medical outcomes research and registries.
And former a Phase I clinical research physician Pui Leung becomes senior clinical research physician for Icon’s development solutions.